MedTrace Logo

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

NCT01772771 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 12000

Last updated 2026-03-03

No results posted yet for this study

Summary

This study performs standardized testing of tumor tissue samples to learn which genes are mutated (have changed) in order to provide personalized cancer therapy options to cancer patients at MD Anderson. This may help doctors use testing information on tumors to identify clinical trials that may be most relevant to patients. Researchers may also use the information learned from this study to develop a database of the different kinds of mutations in cancer-related genes.

Conditions

  • Glioma
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Melanoma
  • Sarcoma

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of blood, saliva/buccal swab samples

OTHER

Genetic Testing

Correlative studies

OTHER

Medical Chart Review

Review of medical records

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Funda Meric-Bernstam · M.D. Anderson Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-01
Primary Completion
2032-03-01
Completion
2033-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01772771 on ClinicalTrials.gov